| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/06/2003 | US20030026862 (+)-Cycloolivil as antioxidant obtained from a new natural source namely stereospermum personatum |
| 02/06/2003 | US20030026812 Administering amylin, or peptide antagonist thereof |
| 02/06/2003 | US20030026811 Health food and preparation having an anti-obesity effect |
| 02/06/2003 | CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs) |
| 02/06/2003 | CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a |
| 02/06/2003 | CA2454803A1 Probiotic bifidobacterium strains |
| 02/06/2003 | CA2453894A1 Antisense modulation of hormone-sensitive lipase expression |
| 02/06/2003 | CA2453653A1 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 02/06/2003 | CA2453019A1 Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof |
| 02/06/2003 | CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2452256A1 Methods of inducing differentiation of stem cells |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | WO2002014280A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1281397A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 02/05/2003 | EP1281351A2 Diabetes management system |
| 02/05/2003 | EP1281325A1 Nutritional composition preventing bacterial overgrowth |
| 02/05/2003 | EP1280911A2 Regulatory nucleic acid sequences of the ABC1 gene |
| 02/05/2003 | EP1280899A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 02/05/2003 | EP1280888A1 Cell culture method, cell cluster obtained by said methods and use thereof |
| 02/05/2003 | EP1280827A1 Agonists/antagonists of the gpr56 receptor as appetite control agents |
| 02/05/2003 | EP1280812A1 Cyclipostins, a method for their production and the use of the same |
| 02/05/2003 | EP1280806A1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| 02/05/2003 | EP1280801A2 Hydantoin-containing glucokinase activators |
| 02/05/2003 | EP1280799A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 02/05/2003 | EP1280797A1 Inhibitors of dipeptidyl peptidase iv |
| 02/05/2003 | EP1280788A1 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or 2-keto-l-gulonate esters |
| 02/05/2003 | EP1280784A2 Biologically active 4h-benzo 1,4]oxazin-3-ones |
| 02/05/2003 | EP1280783A2 Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators |
| 02/05/2003 | EP1280782A2 Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment |
| 02/05/2003 | EP1280779A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | EP1280776A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 02/05/2003 | EP1280774A1 Substituted indoles as parp inhibitors |
| 02/05/2003 | EP1280757A2 New gamma selective retinoids |
| 02/05/2003 | EP1280543A2 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom |
| 02/05/2003 | EP1280537A2 Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof |
| 02/05/2003 | EP1280533A2 Aldosterone antagonist composition for release during aldosterone acrophase |
| 02/05/2003 | EP1280522A2 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use |
| 02/05/2003 | EP1280518A2 Liposome drug delivery |
| 02/05/2003 | EP1223918B1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 02/05/2003 | EP1086078B1 Neuropeptide y5 receptor antagonists |
| 02/05/2003 | EP1019062B1 Osteoblast-specific mitogens and drugs containing such compounds |
| 02/05/2003 | EP0993433B1 Method for producing calcium pyruvates |
| 02/05/2003 | EP0984960B1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists |
| 02/05/2003 | EP0871463B1 Regulation of eating behavior |
| 02/05/2003 | CN1395581A Recombinant antibodies to human IL-1 beta |
| 02/05/2003 | CN1395574A Food product and producing method |
| 02/05/2003 | CN1395567A New imidazole derivatives |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395560A Glyburide composition |
| 02/05/2003 | CN1395558A Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 02/05/2003 | CN1395555A Calcium dicarboxylate ethers, method of making same, and treatment of vascular disease and diabetes therewith |
| 02/05/2003 | CN1394859A Intermediate for preparing cyclopentane formamide compound and its preparation method |
| 02/05/2003 | CN1394638A New medicine for curing diobetes |
| 02/05/2003 | CN1394635A Wild chrysanthemum granules and preparation method |
| 02/05/2003 | CN1394623A Health-care food capable of regulating blood sugar and preparing method thereof |
| 02/05/2003 | CN1394620A Sugar-reducing Chinese medicine capsule |
| 02/05/2003 | CN1394614A Health-care product capable of regulating blood-lipid and its preparation method |
| 02/05/2003 | CN1394520A Method for producing sugar-reducing soluble granules richly containing alpha-linolenic acid, lecithin and trivalent chromium |
| 02/05/2003 | CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/05/2003 | CN1100747C Dialkyl ethers containing terinal caroxy or tetrazole group |
| 02/04/2003 | US6515133 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. |
| 02/04/2003 | US6515117 C-aryl glucoside SGLT2 inhibitors and method |
| 02/04/2003 | US6515021 The compounds according to the invention have pronounced activity in the fields of cell differentiation and cell proliferation |
| 02/04/2003 | US6515005 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 02/04/2003 | US6515003 Useful in the treatment of diseases related to lipid and carbohydrate metabolism |
| 02/04/2003 | US6515002 Compounds and compositions for treating C1s-mediated diseases and conditions |
| 02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
| 02/04/2003 | US6514976 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/04/2003 | US6514970 Urotensin-II receptor antagonists |
| 02/04/2003 | US6514968 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising |
| 02/04/2003 | US6514952 For the treatment and prophylaxis of diseases which are caused by an undesired extent of leucocyte adhesion and/or leucocyte migration such as rheumatoid arthritis or allergic disorders |
| 02/04/2003 | US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 02/04/2003 | US6514544 Beverage for increasing the body's capacity to break down alcohol and method thereof |
| 02/04/2003 | US6514527 Compositions comprising a mixture of bioflavonols |
| 02/04/2003 | CA2272927C Dimesylate salts of neuropeptide y ligands |
| 02/04/2003 | CA2178479C Chroman derivatives |
| 01/30/2003 | WO2003008595A2 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 01/30/2003 | WO2003008590A1 Human mitochondrial gpat |
| 01/30/2003 | WO2003008576A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 01/30/2003 | WO2003008574A1 Mutations in ion channels |
| 01/30/2003 | WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008446A1 Polypeptides relating to signal transfer of advanced glycation end product receptor |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008425A1 Novel bisphosphonate derivatives, their preparation methods and uses |
| 01/30/2003 | WO2003008412A2 Hetero-bicyclic crf antagonists |
| 01/30/2003 | WO2003008411A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 01/30/2003 | WO2003008410A2 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | WO2003008409A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/30/2003 | WO2003008407A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 01/30/2003 | WO2003008397A1 An improved process for the preparation of antidiabetic phenoxazine compounds |
| 01/30/2003 | WO2003008392A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 01/30/2003 | WO2003008388A1 I-form crystal of n-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}-n'-propylurea and process for producing the same |
| 01/30/2003 | WO2003008387A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |